- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05665582
Family Members Affected by Substance Use Disorder - a Follow-up Study
January 2, 2023 updated by: Sorlandet Hospital HF
Family Members Affected by Substance Use Disorder: How do They Cope and What Are Their Expressed Needs for Support?
The present study registration relates to a quantitative sub-study of a larger mixed method study, including also a qualitative sub-study.
Together, these investigations will provide complementary insights.
The quantitative study is a follow-up study of close relatives (> 16 years) of patients in treatment for substance use disorder (SUD) who participated in a group-based 4-day psychoeducational program.
Study Overview
Detailed Description
The study is a follow-up study of close relatives (> 16 years) of patients in treatment for SUDs who participated in a group-based 4-day psychoeducational program.
The investigators will examine whether the family intervention in the specialized treatment services has benefits in terms of typical patient reported outcomes; physical complaints, psychological functioning, family functioning and QoL.
The data collection has been finalized in 2017.
Study Type
Observational
Enrollment (Actual)
271
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Agder
-
Kristiansand, Agder, Norway, 4600
- Addiction Unit - Sørlandet Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Family members of patients in treatment for SUD at a Norwegian addiction treatment unit.
The family members participated in a 4-day psychoeducational program
Description
Inclusion Criteria:
- All participants in a family program
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Affected family members of patients with Substance use disorders
The family sample was recruited from at a Norwegian addiction treatment unit where close relatives of patients in treatment for SUD participated in a family program.
|
A 4-day psychoeducational family program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver burden
Time Frame: Changes from baseline to the 3 months follow-up
|
Changes in Codependency symptomatology measured with the Composite Codependency Scale (CCS).
Participants indicate the extent to which they agreed with each statement on a scale of 1 (strongly disagree) to 5 (strongly agree).
|
Changes from baseline to the 3 months follow-up
|
|
Family functioning
Time Frame: Changes from baseline to the 3 months follow-up
|
Changes in the general family functioning subscale (GFFS).
Respondents complete 12 items with a four-point response scale (1 = strongly agree, 4 = strongly disagree).
A mean score is computed and a higher score indicated greater family dysfunction.
|
Changes from baseline to the 3 months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental distress
Time Frame: Changes from baseline to the 3 months follow-up
|
Changes in the the Hopkins Symptom Checklist (HSCL) 10-item version, which is used to measure mental distress.
This 10-item index maps symptoms of anxiety (4 items) and depression (6 items) on 4-point Likert-type scales ranging from "not bothered at all" (1) to "extremely bothered" (4).
The global severity index (GSI) constitutes the average of all items, with the highest score indicating greater symptom severity during the past week.
|
Changes from baseline to the 3 months follow-up
|
|
Physical complaints
Time Frame: Changes from baseline to the 3 months follow-up
|
Changes in physical complaints, measured on a 10-point ordinal scale (scaled 0 - 10) with higher score indicating more complaints.
|
Changes from baseline to the 3 months follow-up
|
|
Well-being / quality of life
Time Frame: Changes from baseline to the 3 months follow-up
|
Changes in Quality of Life measured with the QoL-5 scale (5 items).
Responses are scored on a five-point scale ranging from very poor to very good QoL and then recoded into a decimal scale from 0.1 to 0.9, where 0.9 is the highest/best score and 0.1 the lowest/worst
|
Changes from baseline to the 3 months follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2016
Primary Completion (Actual)
June 30, 2017
Study Completion (Actual)
December 31, 2017
Study Registration Dates
First Submitted
December 16, 2022
First Submitted That Met QC Criteria
December 16, 2022
First Posted (Actual)
December 27, 2022
Study Record Updates
Last Update Posted (Actual)
January 4, 2023
Last Update Submitted That Met QC Criteria
January 2, 2023
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SSHF_58-04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caregiver Burden
-
University of North Carolina, Chapel HillNorth Carolina Department of Health and Human ServicesRecruitingCaregiver Burnout | Care Giving Burden | Caregiver Wellbeing | Care BurdenUnited States
-
University of North Carolina, Chapel HillNorth Carolina Department of Health and Human ServicesCompletedCaregiver Burnout | Caregiver Stress | Care Giving Burden | Caregiver Wellbeing | Support, Family | Care BurdenUnited States
-
University of North Carolina, Chapel HillNorth Carolina Department of Health and Human ServicesCompletedCaregiver Burnout | Caregiver Stress | Care Giving Burden | Caregiver Wellbeing | Support, Family | Care BurdenUnited States
-
Seda KARAKAYA ERGUNActive, not recruitingCaregiver | Caregiver Burnout | Care BurdenTurkey
-
Uludag UniversityCompleted
-
University of PennsylvaniaNational Institute on Aging (NIA)Recruiting
-
Selcuk UniversityCompletedEducation | CaregiverTurkey (Türkiye)
-
University of Colorado, DenverRecruiting
-
Cedars-Sinai Medical CenterMerck Sharp & Dohme LLC; Foundation for Women's CancersRecruitingFinancial Stress | Caregiver Burnout | Gynecologic Cancers | Financial Toxicity | Financial Burden | Financial NavigationUnited States
-
The University of Hong KongNot yet recruitingPsychological Well-being | Caregiver Burden of Caregivers
Clinical Trials on Family program
-
Social Insurance Institution, FinlandTurku University Hospital; University of TurkuCompletedADHD | Asperger Syndrome | Child Behavior DisordersFinland
-
Massachusetts General HospitalNot yet recruitingBrain Injury | Coma | Emotional Distress | Resilience | Caregivers | Caregiver DistressUnited States
-
Pontificia Universidad Catolica de ValparaisoAgencia Nacional de Investigación y DesarrolloCompletedPhysical Activity | Sleep | Exercise | Health Promotion | Physical Fitness | Sedentary BehaviorsChile
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedAnxiety DisorderCanada
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)CompletedPediatric Disruptive Behaviour DisorderCanada
-
Matthew ModesNational Palliative Care Research CenterRecruitingCritical Illness | Respiratory Failure | Physician-Patient Relations | Family SupportUnited States
-
Universitat Jaume IUniversity of ValenciaNot yet recruiting
-
Boston CollegeChristian Alliance for Orphans; Helping Children Worldwide; Child Reintegration...CompletedEvaluation of a Family Strengthening Program Evaluation in Sierra Leone to Prevent Family SeparationParent-Child Relations | Parenting | Emotion Regulation | Economic ProblemsSierra Leone
-
Human Development Research Foundation, PakistanAutism Speaks; World Health Organization; Grand Challenges Canada; University of... and other collaboratorsCompletedNeurodevelopmental Disorders | Developmental DisabilitiesPakistan
-
NYU Langone HealthNational Institute on Minority Health and Health Disparities (NIMHD)Active, not recruiting